ACP5 and Spondyloenchondrodysplasia with immune dysregulation: Interestingly, the patient (D.II.1) who carried the A536T variant that retained normal suppressive function was also compound heterozygous for ACP5 (Table S2), which is a known cause of spondyloenchondrodysplasia with immune dysregulation that shares features with SLE.